Thank you, Mr. Speaker. Mr. Speaker, this meeting of the Canada Northwest FASD Partnership was to do one main thing and that was to have the first formal meeting of the board of directors of the research centre that's being set up to focus on all the related areas that pertain to FASD, located out of B.C. with a sub-office in Calgary. They have a very strong list of directors; a CEO who is a world leader in the study of FASD. That was the primary function. As well, there was a world conference on FASD attended by people from around the world. There were over 1,200 delegates at this conference in Victoria when we were there, as well. So there was a tremendous focus while we were down there on this issue and all the related work that's being done. They had practitioners and judges, they had doctors, they had a whole host of very high-profile speakers in this area. Thank you.
Michael Miltenberger on Question 504-15(3): Update On Fetal Alcohol Spectrum Disorder
In the Legislative Assembly on February 28th, 2005. See this statement in context.
Return To Question 504-15(3): Update On Fetal Alcohol Spectrum Disorder
Question 504-15(3): Update On Fetal Alcohol Spectrum Disorder
Item 6: Oral Questions
February 27th, 2005
Page 1605
See context to find out what was said next.